Healthcare Marketplace Aumet Acquires Healthcare Supply Chain Startup Platform One

acquistion

B2B healthcare marketplace Aumet on Sunday (Dec. 26) announced that it’s acquired Egypt-based healthcare supply chain solution offering Platform One, giving the U.S.-based company that serves the Middle East and northern Africa more than 5,000 pharmacies in its portfolio. 

The acquisition gives Aumet a foothold across Saudi Arabia, United Arab Emirates, Egypt and Jordan. 

Aumet connects pharmacies and pharmaceutical suppliers across the Middle East and northern Africa through its B2B platform, helping manufacturers, distributors and healthcare providers exchange data to improve overall business efficiency and decision-making. 

Aumet now has access to Platform One’s user network, and Platform One will lead Aumet’s operations in Egypt as part of the deal. 

“Egypt is a crucial market for us, and Platform One has already set the building blocks for what’s next to come,” said Aumet CEO Yahya Aqel in a Martech Vibe report Sunday (Dec. 26). “The synergies that resonated between Aumet and Platform One were clear from the initial phases of interaction as bothcompanies are tech-focused digital solutions providers for the healthcare industry.” 

Pharmacies in Egypt will have access to Aumet’s full suite of products, including Aumet MarketPlace, which connects pharmacies with pharmaceutical suppliers through mobile app and web applications, Aumet Pharmacy, POS and inventory management software solution. 

The collaboration will help pharmacists manage their cash flow and automate their orders with the “Stock Auto-Replenishment” feature connected to Aumet MarketPlace and payment gateway Aumet Pay for pharmacies and their suppliers. 

Related: CVS Expanding Healthcare Services, Expects Sales Jolt 

Earlier this month, drugstore chain and health insurer CVS Health said during its Investor Day 2021 presentations that its sales should grow as it continues to expand its services — both in stores and in people’s homes — as part of its quest to make health care more accessible and easier to afford. 

New CVS Health CEO Karen Lynch said during Investor Day that the company is adapting quickly to changes in consumer habits and riding the momentum from a boost in consumer trust since the COVID-19 pandemic began. 

CVS has handed out more than 50 million COVID vaccines and done about 29 million coronavirus tests through the end of November, she said. Vaccine shots and tests have brought more than 32 million new customers into CVS stores.